Journal profile · Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (miscellaneous)
Aspects of Molecular Medicine
ISSN 2949-6888 · Elsevier · Netherlands
Aspects of Molecular Medicine: impact factor 3.4 (journal website); fully open access; APC about USD 1,385; review about 96 days (submission to acceptance, publisher); 37 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Aspects of Molecular Medicine is published by Elsevier. By OpenAlex counts of its recent articles, its largest topics are Computational Drug Discovery Methods, Natural Antidiabetic Agents Studies and Pharmacological Effects of Natural Compounds, together about 26.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Aspects of Molecular Medicine is a gold open access journal with the goal of rapidly publishing new research articles and short reviews on the molecular and cellular basis of disease. Using tools from biochemistry, molecular and cellular biology, physiology, pharmacology, and pathology, the articles are intended to describe the mechanistic background of disease and make it understandable at the clinical level. The purpose of Aspects of Molecular Medicine is to provide a clinical foundation for basic scientists and a rationalization of disease for the clinician.By publishing recent cutting-edge research, Aspects of Molecular Medicine is complementary to its sister journal, Molecular Aspects of Medicine, which publishes only lengthy review articles on established aspects of molecular medicine. Aspects of Molecular Medicine is affiliated with International Union of Biochemistry and Molecular Biology
From the journal's Aims & Scope
Research area (LetPub): Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (miscellaneous)
Editor-in-chief Angelo AzziPublisher website
Editorial board by country: 3 in mainland China (about 6%); most named United States 15, Italy 12, Argentina 6, Mainland China 3, Iran 3 (53 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Computational Drug Discovery MethodsComputer Science10.7%
- Natural Antidiabetic Agents StudiesMedicine9.5%
- Pharmacological Effects of Natural CompoundsPharmacology, Toxicology and Pharmaceutics6%
- Gut microbiota and healthBiochemistry, Genetics and Molecular Biology4.8%
- Malaria Research and ControlMedicine4.8%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology4.8%
- Extracellular vesicles in diseaseBiochemistry, Genetics and Molecular Biology4.8%
- Adipose Tissue and MetabolismMedicine4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 3.4Publisher website ·
- CiteScore 2026-06
- 4LetPub ·
- CiteScore (publisher)
- 4Publisher website ·
- SJR 2026-06
- 0.62LetPub ·
- SNIP 2026-06
- 0.85LetPub ·
- h-index
- 14OpenAlex ·
- i10-index
- 20OpenAlex ·
- 2-year mean citedness
- 6.27OpenAlex ·
- Self-citation rate
- 2.9%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 36LetPub ·
Articles by year OpenAlex count · 102 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 15 | 15 | 4 |
| 2025 | 37 | 37 | 296 |
| 2024 | 27 | 27 | 195 |
| 2023 | 23 | 23 | 201 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
96 dayssubmission to acceptance · community reports about 15 weeks
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Average review time (community reports)
- about 15 weeksLetPub ·
- Submission to first decision
- 4 daysPublisher website ·
- First decision after review
- 66 daysPublisher website ·
- Submission to acceptance
- 96 daysPublisher website ·
- Acceptance to publication
- 3 daysPublisher website ·
- Submission to publication (journal-reported)
- about 15 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,385 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 2,720 / EUR 2,540 / GBP 2,180 / JPY 337,360 | — | — | |
| LetPub | USD 2,650 | Yes | — | |
| Publisher website | USD 2,770 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare9 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 1
- Reference style
- Numbered, in order of citation
- Templates
- LaTeX and Word
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Highlights
- Required
- Graphical abstract
- Required
- Cover letter
- Required
Article types accepted5
- letter to the editorLetter to the EditorLength not stated
- original researchThe following article types are available for authors:Original Research PapersReview ArticlesShort CommunicationsLetter to the EditorLength not stated
- original research papersOriginal Research PapersLength not stated
- review articlesReview ArticlesLength not stated
- short communicationsShort CommunicationsLength not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- Netherlands
- Language
- English
- ISSN
- 2949-6888
- Society / sponsor
- International Union of Biochemistry and Molecular Biology
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Aspects of Molecular Medicine
What is the impact factor of Aspects of Molecular Medicine?
The journal's website gives an impact factor of 3.4; this is the journal's own figure, as LetPub lists none for it; CiteScore 4, h-index 14.
How long does peer review take at Aspects of Molecular Medicine?
The publisher reports about 96 days (submission to acceptance); authors report an average review time of about 15 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Aspects of Molecular Medicine?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 1; Reference style: Numbered, in order of citation; Templates: LaTeX and Word; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Highlights: Required; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Aspects of Molecular Medicine based?
Of the 53 board members whose country the journal's board page names, 3 (about 6%) are in mainland China; the countries named most often are United States (15), Italy (12) and Argentina (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Aspects of Molecular Medicine?
According to LetPub and DOAJ records, Aspects of Molecular Medicine is indexed in ESCI, Scopus and DOAJ.
Is Aspects of Molecular Medicine open access, and what is the APC?
Aspects of Molecular Medicine is a fully open-access journal. APC about USD 1,385.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .